Advertisement

Topics

First Nonopioid Treatment To Ease Withdrawal Symptoms Approved By FDA

08:46 EDT 17 May 2018 | Kaiser Health News

Regulators say that Lucemyra is not an addiction medicine but that it can be part of a longer-term treatment plan. "The physical symptoms of opioid withdrawal can be one of the biggest barriers for patients seeking help and ultimately overcoming addiction," says Dr. Scot Gottlieb, the FDA's commissioner.

Original Article: First Nonopioid Treatment To Ease Withdrawal Symptoms Approved By FDA

NEXT ARTICLE

More From BioPortfolio on "First Nonopioid Treatment To Ease Withdrawal Symptoms Approved By FDA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...